Ryll Martin J, Zodl Aurelia, Weingarten Toby N, Rabinstein Alejandro A, Warner David O, Schroeder Darrell R, Sprung Juraj
Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany.
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
J Intensive Care Med. 2024 May;39(5):455-464. doi: 10.1177/08850666231212875. Epub 2023 Nov 15.
The Pulmonary Embolism Severity Index (PESI) and simplified PESI (sPESI) predict mortality for patients with PE. We compared PESI/sPESI to the Acute Physiology and Chronic Health Evaluation IV (APACHE-IV) in predicting mortality in patients with PE admitted to the intensive care unit (ICU). Additionally, we assessed the performance of a novel ICU-sPESI score created by adding three clinical variables associated with acuity of PE presentation (intubation, confusion [altered mental status], use of vasoactive infusions) to sPESI.
Using the eICU Collaborative Research Database from 2014 to 2015, we conducted a large retrospective cohort study of adult patients admitted to the ICU with a primary diagnosis of PE. We calculated APACHE-IV, PESI, sPESI, and ICU-sPESI scores and compared their performance for predicting in-hospital mortality using area under the receiver operating characteristic (AUROC) curve. Score thresholds for >99% negative predictive values (NPV) were calculated for each score. Survival was estimated using the Kaplan-Meier method.
We included 1424 PE cases. In-hospital mortality was 6.3% [95% CI: 5.1%-7.6%]. AUROC for APACHE-IV, PESI, and sPESI were 0.870, 0.848, and 0.777, respectively. APACHE-IV and PESI outperformed sPESI (P < 0.01 for both comparisons), while APACHE-IV and PESI demonstrated similar performance (P = 0.322). The ICU-sPESI performance was similar to APACHE-IV and PESI (AUROC = 0.847; AUROC comparison: APACHE-IV vs ICU-sPESI: P = 0.396; PESI vs ICU-sPESI: P = 0.945). Hospital mortality for ICU-sPESI scores 0-2 was 1.1%, and for scores 3, 4, 5, 6, and ≥7 was 8.6%, 11.7%, 29.2%, 37.5%, and 76.9%, respectively. Score thresholds for >99% NPV were ≤48 for APACHE-IV, ≤115 for PESI, and 0 points for sPESI and ICU-sPESI.
By accounting for severity of PE presentation, our newly proposed ICU-sPESI score provided improved PE mortality prediction compared to the original sPESI score and offered excellent discrimination of mortality risk.
肺栓塞严重程度指数(PESI)和简化PESI(sPESI)可预测肺栓塞患者的死亡率。我们比较了PESI/sPESI与急性生理与慢性健康状况评估IV(APACHE-IV)在预测入住重症监护病房(ICU)的肺栓塞患者死亡率方面的表现。此外,我们评估了一种新的ICU-sPESI评分的性能,该评分是通过在sPESI基础上增加三个与肺栓塞表现的急性程度相关的临床变量(插管、意识模糊[精神状态改变]、使用血管活性输注)而创建的。
利用2014年至2015年的eICU协作研究数据库,我们对入住ICU且初步诊断为肺栓塞的成年患者进行了一项大型回顾性队列研究。我们计算了APACHE-IV、PESI、sPESI和ICU-sPESI评分,并使用受试者操作特征(AUROC)曲线下面积比较它们在预测院内死亡率方面的表现。计算每个评分的>99%阴性预测值(NPV)的评分阈值。使用Kaplan-Meier方法估计生存率。
我们纳入了1424例肺栓塞病例。院内死亡率为6.3%[95%CI:5.1%-7.6%]。APACHE-IV、PESI和sPESI的AUROC分别为0.870、0.848和0.777。APACHE-IV和PESI的表现优于sPESI(两项比较P均<0.01),而APACHE-IV和PESI表现相似(P = 0.322)。ICU-sPESI的表现与APACHE-IV和PESI相似(AUROC = 0.847;AUROC比较:APACHE-IV与ICU-sPESI:P = 0.396;PESI与ICU-sPESI:P = 0.945)。ICU-sPESI评分为0 - 2分的患者院内死亡率为1.1%,评分为3、4、5、6和≥7分的患者院内死亡率分别为8.6%、11.7%、29.2%、37.5%和76.9%。APACHE-IV的>99%NPV的评分阈值≤48,PESI≤115,sPESI和ICU-sPESI为0分。
通过考虑肺栓塞表现的严重程度,我们新提出的ICU-sPESI评分与原始sPESI评分相比,在预测肺栓塞死亡率方面有改进,并能很好地区分死亡风险。